Fate Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:FATE Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 May 26	SellUS$48,084	Cindy Tahl	Individual	25,590	US$1.88
20 May 26	SellUS$54,482	Bahram Valamehr	Individual	28,946	US$1.88
09 Jan 26	SellUS$11,275	Cindy Tahl	Individual	10,589	US$1.06
09 Jan 26	SellUS$5,557	Bahram Valamehr	Individual	5,190	US$1.07
04 Aug 25	SellUS$15,396	Bahram Valamehr	Individual	14,466	US$1.06
04 Aug 25	SellUS$9,573	Cindy Tahl	Individual	9,037	US$1.06

Insider Trading Volume

Insider Buying: FATE insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of FATE?
Owner Type	Number of Shares	Ownership Percentage
State or Government	90,000	0.0772%
Individual Insiders	1,732,255	1.49%
Hedge Funds	12,872,946	11%
General Public	25,184,014	21.6%
Institutions	76,679,971	65.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 68.26% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11%	Redmile Group, LLC	12,872,946	US$25.9m	0%	1.52%
8.85%	ARK Investment Management LLC	10,312,167	US$20.7m	0%	0.13%
8.64%	BlackRock, Inc.	10,068,614	US$20.2m	-1.06%	no data
4.26%	Boxer Capital Management, LLC	4,960,910	US$10.0m	0%	100.0%
3.6%	Vanguard Capital Management, LLC	4,192,063	US$8.4m	0%	no data
3.55%	Vanguard Portfolio Management, LLC	4,134,585	US$8.3m	0%	no data
3.53%	Acadian Asset Management LLC	4,120,200	US$8.3m	40.5%	0.01%
2.97%	Two Sigma Investments, LP	3,466,786	US$7.0m	99.9%	0.01%
2.9%	Johnson & Johnson Innovation - JJDC, Inc.	3,379,064	US$6.8m	0%	0.94%
2.55%	Renaissance Technologies LLC	2,974,683	US$6.0m	26%	0.01%
2.51%	AQR Capital Management, LLC	2,923,910	US$5.9m	156%	no data
2.22%	Geode Capital Management, LLC	2,590,429	US$5.2m	4.95%	no data
1.94%	State Street Global Advisors, Inc.	2,263,173	US$4.5m	-0.09%	no data
1.56%	UBS Asset Management AG	1,822,530	US$3.7m	352%	no data
1%	Tang Capital Management, LLC	1,167,773	US$2.3m	0%	0.11%
0.88%	The Goldman Sachs Group, Inc.	1,026,838	US$2.1m	-9.26%	no data
0.81%	Citadel Advisors LLC	942,926	US$1.9m	25.8%	no data
0.76%	Dimensional Fund Advisors LP	883,790	US$1.8m	-44%	no data
0.75%	Irenic Capital Management LP	878,055	US$1.8m	0%	0.14%
0.7%	Northern Trust Global Investments	811,920	US$1.6m	10.8%	no data
0.69%	Monaco Asset Management S.A.M.	810,000	US$1.6m	-2.41%	0.44%
0.68%	Bruce & Co Inc	789,188	US$1.6m	8.23%	0.44%
0.66%	Morgan Stanley	765,306	US$1.5m	-12.7%	no data
0.65%	Charles Schwab Investment Management, Inc.	756,273	US$1.5m	-3.61%	no data
0.56%	Vanguard Fiduciary Trust Company	653,761	US$1.3m	-0.76%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/16 23:07
End of Day Share Price	2026/06/16 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fate Therapeutics, Inc. is covered by 25 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jack Allen	Baird
Tazeen Ahmad	BofA Global Research
Amanda Murphy	BTIG